株式会社ＦＸプライムbyＧＭＯに対する検査結果に基づく勧告について
https://www.fsa.go.jp/sesc/news/c_2020/2020/20200804-3.htmlThe evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
株式会社ＦＸプライムbyＧＭＯに対する検査結果に基づく勧告について
Open the archived HTML with saved-time metadata attached.
This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.
This page reports a recommendation issued by the Securities and Exchange Surveillance Commission against FX Prime by GMO Co., Ltd. based on inspection findings. The company displayed "No slippage (0%)" in web and magazine advertisements from September 2017 to November 2019 for its foreign exchange margin trading tool. However, the company's system was actually unable to eliminate slippage (the difference between order and execution prices), and the company had received customer reports of slippage occurring. Despite this, the company failed to conduct adequate verification and made false representations, violating the Financial Instruments and Exchange Act Article 37, Paragraph 2.
